CO5021227A1 - Azoles hidrosolubles como antifungicos de amplio espectro - Google Patents

Azoles hidrosolubles como antifungicos de amplio espectro

Info

Publication number
CO5021227A1
CO5021227A1 CO99029778A CO99029778A CO5021227A1 CO 5021227 A1 CO5021227 A1 CO 5021227A1 CO 99029778 A CO99029778 A CO 99029778A CO 99029778 A CO99029778 A CO 99029778A CO 5021227 A1 CO5021227 A1 CO 5021227A1
Authority
CO
Colombia
Prior art keywords
alkyl
radical
amino
hydroxy
aryl
Prior art date
Application number
CO99029778A
Other languages
English (en)
Inventor
Lieven Meerpoel
Leo Backx
Der Veken Louis Jozef Elisabeth Van
Frank Christopher Odds
Jan Heeres
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CO5021227A1 publication Critical patent/CO5021227A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un compuesto de la fórmulaUna forma de N-óxido, una sal de adición farmacéuticamente aceptable o una forma estereisómericamente posible del mismo, en el cual L representa un radical de la fórmula en la cual cada Alk representa independientemente alcanodiilo C1-6 optativamente sustituido con hidroxi o alquiloxi C1-4 ;cada n es independientemente 1, 2 ó 3; Y representa O, S o NR2 ; cada R1 representa independientemente hidrógeno, arilo, Het1 o alquilo C1-6 optativamente sustituido con uno, dos o tres sustituyentes cada uno de los cuales es independientemente seleccionado entre halo, hidroxi, mercapto, alquiloxi C1-4 , alquiltio C1-4 , ariloxi, ariltio, arilalquiloxi C1-4 , arilalquiltio C1-4 , ciano, amino, mono- o di(alquilo C1-4 )-amino, mono- o di(aril)amino, mono- o di(arilalquilC1-4 )amino, alquiloxicarbonilamino C1-4 , benciloxicarbonilamino, aminocarbonilo, carboxilo, alquiloxicarbonilo C1-4 , guanidinilo, arilo o Het2 ; Cada R2 independientemente representa hidrógeno o alquilo C1-6 , o en el caso en que R1 y R2 están unidos al mismo átomo de nitrógeno pueden tomarse juntos para formar un radical heterocíclico seleccionado entre morfolinilo, pirrolidinilo, piperidinilo, homopiperidinilo o piperazinilo; dicho radical heterocíclico puede estar optativamente sustituido con alquilo C1-4 , arilo, Het2 , arilalquilo C1-4 , Het2 alquilo C1-4 , - 2 -hidroxialquilo C1-4 , amino, mono- o di(alquilo C1-4 )amino, aminoalquilo C1-4 , mono- o di(alquil C1-4 )aminoalquilo C1-4 , carboxilo, aminocarbonilo, alquiloxicarbonilo C1-4 , alquiloxicarbonilamino C1-4 o mono- o di(alquil C1-4 )aminocarbonilo o Pueden tomarse juntos para formar un radical azido; Cada R3 representa independientemente hidrógeno, hidroxi o alquiloxi C1-4 ; arilo representa fenilo, naftalenilo, 1,2,3,4-tetrahidro-naftalenilo, indenilo o indanilo; cada uno de dichos grupos arilo puede estar optativamente sustituido con uno o más sustituyentes seleccionados entre halo, alquilo C1-4 , hidroxi, alquiloxi C1-4 , nitro amino, trifluorometilo, hidroxialquilo C1-4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , mono- o di(alquil C1-4 )aminoalquilo C1-4 ,HET1 representa un radical heterocíclico monocíclico o bicíclico; radical heterocíclico monocíclico que es seleccionado entre el grupo que consiste en piridinilo, piperidinilo, homopiperidinilo, pirazinilo, pirimidinilo, piridazinilo, triazinilo, triazolilo, piranilo, tetrahidropiranilo, imidazolilo, imidazolinilo, imidazolidinilo, pirazolilo, pirazolinilo, pirazolidinilo, tiazolilo, tiazolidinilo, isotiazolilo, oxazolilo, oxazolidinilo, isoxazolilo, pirrolilo, pirrolinilo, pirrolidinilo, furanilo, tetrahidrofuranilo, tienilo, tiolanilo, dioxolanilo, y dicho radical heterociclo bicíclico puede ser seleccionado entre el grupo que consiste en quinolinilo, 1,2,3,4AND#8209; tetrahidroquinolinilo, isoquinolinilo, quinoxalinilo, quinazolinilo, ftalazinilo, cinolinilo, cromannilo, tiocromanilo, 2HAND#8209;cromenilo, 1,4AND#8209;benzodioxanilo, indolilo, isoindolilo, indolinilo, indazolilo, purinilo, pirrolopiridinilo, furanopiridinilo, tienopiridinilo, benzotiazolilo, banzoxazolilo, bencisotiazolilo, bencisoxazolilo, bencimidazolilo, Benzofuranilo, benzotienilo; por lo cual cada uno de dichos heterociclos monoAND#8209; o bicíclicos puede estar optativamente sustituido con uno o, en lo posible, más sustituyentes seleccionados entre el grupo que consiste en halo, alquilo C1AND#8209;4 , hidroxi, alquiloxi C1AND#8209;4 , nitro, amino, trifluorometilo, hidroxialquilo C1AND#8209;4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , monoAND#8209; o di(alquil C1-4 )aminoalquilo C1-4 , arilo o arilalquilo C1-4 , Het2 es igual a Het1 y también puede ser un heterociclo monocíclico seleccionado entre el grupo que consiste en piperazinilo, homopiperazinilo, 1,4AND#8209;dioxanilo, morfolinilo, tiomorfolinilo; por lo cual cada uno de dichos heterociclos monocíclicos puede estar optativamente sustituido con uno o, en lo posible, más sustituyentes seleccionados entre el grupo que consiste en halo, alquilo C1-4 , hidroxi, alquiloxi C1AND#8209;4 , nitro, amino, trifluorometilo, hidroxialquilo C1-4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , monoAND#8209; o di(alquil C1-4 ,) aminoalquilo C1AND#8209;4 , arilo o arilalquilo C1AND#8209;4 , R6 representa hidrógeno o alquilo C1-4 R7 representa hidrógeno o alquilo C1-4 o R6 y R7 juntos forman un radical bivalente de la fórmula AND#8209;R6 AND#8209;R7 AND#8209;en la cualAND#8209;R6 AND#8209;R7 AND#8209; es: AND#8209;N=CHAND#8209; (i), AND#8209;CH=NAND#8209; (ii), AND#8209;CH=CHAND#8209; (iii), AND#8209;CH2 AND#8209;CH2 AND#8209; (iv),donde un átomo de hidrógeno de los radicales (i) y (ii) puede ser reemplazado con un radical alquilo C1-4 , y uno o más átomos de hidrógeno de los radicales (iii) y (iv) pueden ser reemplazados con un radical alquilo C1-4 ; D representa un radical de la fórmula En la cual X es N o CH; R4 es hidrógeno o halo; R5 es halo.
CO99029778A 1998-05-14 1999-05-13 Azoles hidrosolubles como antifungicos de amplio espectro CO5021227A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98201588A EP0957101A1 (en) 1998-05-14 1998-05-14 Water soluble azoles as broad-spectrum antifungals

Publications (1)

Publication Number Publication Date
CO5021227A1 true CO5021227A1 (es) 2001-03-27

Family

ID=8233724

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99029778A CO5021227A1 (es) 1998-05-14 1999-05-13 Azoles hidrosolubles como antifungicos de amplio espectro

Country Status (32)

Country Link
US (2) US6384030B1 (es)
EP (3) EP0957101A1 (es)
JP (2) JP2002514646A (es)
KR (2) KR100593395B1 (es)
CN (2) CN1137118C (es)
AR (2) AR016482A1 (es)
AT (2) ATE238296T1 (es)
AU (2) AU751135B2 (es)
BG (2) BG64388B1 (es)
BR (2) BR9911057A (es)
CA (2) CA2331187C (es)
CO (1) CO5021227A1 (es)
CZ (2) CZ298702B6 (es)
DE (2) DE69902461T2 (es)
DK (1) DK1077976T3 (es)
EE (2) EE04311B1 (es)
ES (2) ES2198915T3 (es)
HK (2) HK1033312A1 (es)
HR (2) HRP20000741B1 (es)
HU (2) HUP0103536A3 (es)
IL (2) IL139649A (es)
MY (2) MY122147A (es)
NO (2) NO319851B1 (es)
NZ (2) NZ507965A (es)
PL (2) PL194085B1 (es)
PT (1) PT1077976E (es)
SI (1) SI1077976T1 (es)
SK (2) SK286156B6 (es)
TR (2) TR200003323T2 (es)
TW (2) TWI259835B (es)
WO (2) WO1999058530A1 (es)
ZA (2) ZA200007173B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
AU3402301A (en) * 2000-03-07 2001-09-17 Ranbaxy Laboratories Limited Azole compounds as therapeutic agents for fungal infections
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
AR052342A1 (es) * 2004-12-21 2007-03-14 Janssen Pharmaceutica Nv Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores
WO2011144653A1 (en) * 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral triazolones
US11028078B2 (en) * 2011-09-07 2021-06-08 The Johns Hopkins University Itraconazole analogs and use thereof
US9346791B2 (en) 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
US9663499B2 (en) * 2013-06-07 2017-05-30 The California Institute For Biomedical Research Small molecule inhibitors of fibrosis
WO2016087878A1 (en) 2014-12-05 2016-06-09 Pulmocide Limited Antimycotic compound
WO2016094570A1 (en) * 2014-12-10 2016-06-16 The California Institute For Biomedical Research Small molecule inhibitors of fibrosis
DK3298006T3 (da) 2015-05-21 2020-03-30 Pulmocide Ltd Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf
CN105237392B (zh) * 2015-11-24 2017-12-12 辽宁渤大化工有限公司 芳烷基水杨酸及其衍生物的制备方法
AU2018321287A1 (en) 2017-08-20 2020-04-02 University Of Connecticut Azole analogues and methods of use thereof
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
PL172358B1 (en) * 1992-03-18 1997-09-30 Janssen Pharmaceutica Nv Stereoisomeric form of itraconazole or saperconazole and method of obtaining same
AU681753B2 (en) * 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
NZ278882A (en) * 1994-01-24 1997-06-24 Janssen Pharmaceutica Nv Piperazine-containing azole antifungal compounds
FI98688C (fi) * 1994-07-20 1997-07-25 Nokia Telecommunications Oy Menetelmä lyhytsanomalähetyksen käynnistämiseksi solukkoradiojärjestelmässä, solukkoradiojärjestelmä sekä solukkoradiojärjestelmän tilaajarekisteri
ATE240319T1 (de) * 1995-06-02 2003-05-15 Schering Corp Antifungale tetrahydrofurane
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
DE69824834T2 (de) 1997-02-11 2005-07-21 Janssen Pharmaceutica N.V. Azole enthaltende antifungale aminosäure-ester
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Also Published As

Publication number Publication date
WO1999058530A1 (en) 1999-11-18
TW572899B (en) 2004-01-21
ATE238296T1 (de) 2003-05-15
NO20005712L (no) 2000-12-07
DE69907171D1 (de) 2003-05-28
CZ20004109A3 (en) 2001-05-16
PL194085B1 (pl) 2007-04-30
ZA200007459B (en) 2002-09-13
HK1032781A1 (en) 2001-08-03
WO1999058529A1 (en) 1999-11-18
HRP20000741A2 (en) 2001-06-30
HRP20000741B1 (en) 2009-02-28
NO319851B1 (no) 2005-09-19
TWI259835B (en) 2006-08-11
EE200000651A (et) 2002-04-15
JP2002514645A (ja) 2002-05-21
MY122147A (en) 2006-03-31
PT1077976E (pt) 2002-12-31
HUP0102031A3 (en) 2002-10-28
NO319760B1 (no) 2005-09-12
EP1077976A1 (en) 2001-02-28
BG104933A (en) 2001-10-31
NZ507965A (en) 2002-05-31
US6384030B1 (en) 2002-05-07
IL139647A0 (en) 2002-02-10
CZ298702B6 (cs) 2007-12-27
MY120248A (en) 2005-09-30
EP1077975A1 (en) 2001-02-28
BR9911057A (pt) 2001-02-06
BG64954B1 (bg) 2006-10-31
ATE221884T1 (de) 2002-08-15
BG64388B1 (bg) 2004-12-30
AU758876B2 (en) 2003-04-03
PL344047A1 (en) 2001-09-24
AU4141799A (en) 1999-11-29
KR20010041480A (ko) 2001-05-25
CA2331187C (en) 2008-11-18
AR016480A1 (es) 2001-07-04
NO20005713L (no) 2001-01-11
CN1135229C (zh) 2004-01-21
DE69902461D1 (de) 2002-09-12
EP1077975B1 (en) 2003-04-23
HUP0102031A2 (hu) 2002-05-29
ES2198915T3 (es) 2004-02-01
EE200000657A (et) 2002-04-15
HK1033312A1 (en) 2001-08-24
SI1077976T1 (en) 2003-02-28
KR100575147B1 (ko) 2006-05-03
NZ507966A (en) 2002-10-25
CN1300287A (zh) 2001-06-20
HUP0103536A3 (en) 2002-08-28
CA2331187A1 (en) 1999-11-18
AU4361599A (en) 1999-11-29
EE04311B1 (et) 2004-06-15
SK16812000A3 (sk) 2001-08-06
PL194086B1 (pl) 2007-04-30
DE69907171T2 (de) 2004-02-05
TR200003323T2 (tr) 2001-02-21
AR016482A1 (es) 2001-07-04
TR200003322T2 (tr) 2001-02-21
PL344037A1 (en) 2001-09-24
DK1077976T3 (da) 2002-12-02
SK16822000A3 (sk) 2001-07-10
EP1077976B1 (en) 2002-08-07
DE69902461T2 (de) 2003-04-10
US6448244B1 (en) 2002-09-10
ZA200007173B (en) 2002-03-04
HRP20000740B1 (en) 2003-12-31
NO20005712D0 (no) 2000-11-13
BR9910448A (pt) 2001-01-02
CN1137118C (zh) 2004-02-04
BG104717A (en) 2001-07-31
ES2182531T3 (es) 2003-03-01
CZ20004108A3 (en) 2001-05-16
HUP0103536A2 (hu) 2002-07-29
KR20010042852A (ko) 2001-05-25
SK285763B6 (sk) 2007-07-06
CZ299481B6 (cs) 2008-08-13
IL139649A0 (en) 2002-02-10
NO20005713D0 (no) 2000-11-13
IL139649A (en) 2004-09-27
SK286156B6 (sk) 2008-04-07
JP2002514646A (ja) 2002-05-21
EP0957101A1 (en) 1999-11-17
EE04346B1 (et) 2004-08-16
AU751135B2 (en) 2002-08-08
CA2331141C (en) 2008-10-28
CN1300288A (zh) 2001-06-20
CA2331141A1 (en) 1999-11-18
KR100593395B1 (ko) 2006-06-28
HRP20000740A2 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
CO5021227A1 (es) Azoles hidrosolubles como antifungicos de amplio espectro
RS52431B (en) QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS
ES2283716T3 (es) Inhibidores de la replicacion del virus sincitial respiratorio.
ES2225231T3 (es) Compuestos heterociclicos, utiles como inhibidores de tirosina quinasas.
ES2593256T3 (es) Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
AR054889A1 (es) Derivados de quinolina como agentes bacterianos
CO5180553A1 (es) Derivados de pirimidona de la formula (1) o sales de los mismos y medicamentos que contienen dichos derivados como ingrediente activo
ES2704704T3 (es) Nuevos derivados de azaindol como inhibidores selectivos de la histona desacetilasa (HDAC) y composiciones farmacéuticas que los comprenden
ES2671502T3 (es) Proceso novedoso para preparar compuestos para su uso en el tratamiento de cáncer
AR048522A1 (es) Derivados sustituidos de diaza-espiro-(5.5)-undecano y su uso como antagonistas de neuroquininas
AR048521A1 (es) Derivados sustituidos de diaza-espiro-(4.5)-decano y su uso como antagonistas de neuroquininas
EA201290520A1 (ru) Производные дифенилпиразолопиридинов, их получение и применение в качестве модуляторов нуклеарного рецептора not
HRP20090294T1 (en) Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
HRP20080024T3 (en) Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
ES2226844T3 (es) Aminoazaciclos heterociclicos sustituidos utiles como agentes activos sobre el sistema nervioso central.
WO2011058113A1 (en) Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
CA2944801C (en) Analogs of 4h-pyrazolo[1,5-a]benzimidazole compounds as parp inhibitors
WO2010051043A1 (en) Benzoxazole kinase inhibitors and methods of use
NZ334971A (en) 2-cyanoiminoimidazole derivatives for use as phosphodiesterase (PDE) IV inhibitors
NZ586610A (en) Novel cytostatic 7-deazapurine nucleosides
NO20063681L (no) Aryloksyalkylkarbamattype derivater, fremgangsmate for fremstilling derav og anvendelse av derivatene i terapeutiske midler
CO6251238A2 (es) Tetrahidrobenzo-1,4-diacepinas arilo - y heteroarilo - sustituidas y su uso para bloquear la recaptacion de norepinefrina dapamina y serotanina
GB1303081A (es)
RU99109032A (ru) Производные 2-цианоиминоимидазола, ингибирующие pde iv
ES2370049T3 (es) Nuevos derivados de imidazolonas, su preparación como medicamentos, composiciones farmacéuticas, utilización como inhibidores de proteínas quinasas, en particular cdc7.